Convey Health is a leading healthcare platform that uses technology and processes to improve government-sponsored health plans, including Medicare Advantage (“MA”). Our proprietary modular technology and end-to-end solutions replace or supplement our clients’ existing systems and processes, enabling us to help health plans attract and retain members, improve revenue accuracy, drive cost savings, facilitate regulatory […]

The company intends to focus on businesses in Asia operating in the telecommunications, media, and technology (“TMT”) sectors. We intend to seek targets with an enterprise value of approximately $250 million to $1 billion. (Incorporated in Delaware) Sophie Ye Tao, our president and CEO, has been an active investor in China and the U.S. since […]

WalkMe is the defining solution enabling organizations to better realize the value of their software investments. Using our cloud-based Digital Adoption Platform, users—employees and customers of organizations—can navigate websites, SaaS applications, and mobile apps through a digital, GPS-like experience to accomplish any task from simple, online transactions, to complex cross-application software processes, to fully autonomous experiences that […]

We are an innovative biopharmaceutical company developing next-generation therapeutics based on our proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Our initial focus is on developing a novel class of T cell engagers (TCEs), and our lead product candidates are designed to target clinically validated drug targets. While […]

We pioneered the world’s first purpose-built AI-powered extended detection and response, or XDR, platform to make cybersecurity defense truly autonomous, from the endpoint and beyond. Our Singularity Platform instantly defends against cyberattacks – performing at a faster speed, greater scale and higher accuracy than possible from any single human or even a crowd. With digital […]

(Note: This is an IPO of 48 million American Depositary Shares (ADS), representing 96 million Class A ordinary shares.)  We are the largest online recruitment platform in China, based on average MAU in 2020, according to the CIC report. (We had 19.8 million MAU in 2020.) We connect job seekers and enterprise users (employers or […]

(Note: This is an IPO of 3,623,000 American Depositary Shares (ADS). Each ADS represents nine Class A ordinary shares. Zhangmen Education is incorporated in the Cayman Islands.) We are a leading online education company in China, focused on providing personalized online courses to K-12 students, according to the Frost & Sullivan Report. Our core course […]

We aim to be the trusted partner of choice for the services economy by providing modern, vertically-tailored software solutions that enable our customers to drive growth and new business opportunities, manage and scale their operations, and improve customer relationships. EverCommerce is a leading provider of integrated, vertically-tailored software-as-a-service (SaaS) solutions for service-based small- and medium-sized […]

We believe that we are a leading synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Our synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, […]

We are a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs), using our proprietary expanded genetic code technology platform that allows us to incorporate, in a site-specific manner, synthetic amino acids (SAAs) into proteins within living cells. Our product candidates are designed to overcome the inherent limitations […]